![]() |
Animal Care Committee Cercopithecine herpesvirus 1 (Herpes B virus) |
![]() |
Causative Agent
DNA Herpesvirus. There are more than 35
herpesviruses of NHPs, most of which are not zoonotic. This disease has
been described as one of the most feared infections of non-human primate
handlers. First reported case of encephalitis caused by B virus in monkey handler was in 1932. Called B virus after the initials W.B. of the
first patient. 23 additional cases described
through 1973. Four cases including first known person to person
transmission occurred in Pensacola, FL in 1987. Most of these cases
resulted in encephalitis and 20 resulted in fatalities. In 1988 two
confirmed cases occurred. Both were
identified early and clinical signs were averted by administration of Acyclovir.
Reservoir and Incidence
The virus is enzootic in rhesus, cyno and other
Asiatic monkeys of macaque genus. Baboons, Chimpanzees, and African Greens
have also shown positive titers. Young monkeys can be infected by adult
carriers as soon as they lose maternal antibody. One study found that 80%
of adult monkeys in a closed colony had been infected . The virus
has been isolated from
trigeminal and lumbosacral ganglia in clinically normal sero-positive rhesus and
cyno's.
Transmission
Transmission of the virus is basically by direct
contact. Transmission to man is thought to occur via bites, scratches,
aerosols, or improper handling of contaminated monkey tissues. Virus has
been isolated from saliva, blood, urine, feces, and
kidney tissue cultures of infected monkeys. Most cases have occurred in
people exposed to monkeys or monkey tissues. One case occurred by common use of an over-the-counter antibiotic ointment passing the virus from an
infected
individual to another person. An additional case occurred by self
inoculation of a needle, after the needle had been use for blood collection.
The virus has been isolated from animals that had no visible lesions.
AN INFECTED MONKEY SHOULD BE CONSIDERED INFECTED FOR LIFE.
Disease in NHP
The animal may be completely asymptomatic. The virus may cause mild cold sore type lesions of mucous membranes, dorsum of the tongue, lips or face; similar to those caused by Herpes simplex in man. These usually heal spontaneously in 7 to 14 days. There may be mild conjunctivitis and nasal discharge are present. In some animals the disease may be severe and cause considerable discomfort as well as neurological signs and symptoms. The virus remains latent and may reactivate spontaneously or in ties of stress resulting in virus shedding. An animal should be considered to be infected for life. AN INFECTED ANIMAL CAN APPEAR NORMAL!
Disease in Humans
The disease has been characterized by a variety of
symptoms which generally occur within a month of exposure. Symptoms have
included vesicular skin lesions at or near the site of inoculation, localized
neurological symptoms, ascending paralysis, and ultimately encephalitis.
Death usually occurs 3 to 21 days after the appearance of clinical signs.
A unique feature of the Pensacola cases was the occurrence of mild disease in 2
of 4 patients. Both of these received Acyclovir early in the course of the
disease. They became culture negative and lesions resolved during therapy.
Since there is a high percentage of infection in monkeys yet relatively few
human cases, risk of acquiring infection appears to be low. Possible
reasons for this apparently low rate of transmission may include:
1. Infrequent virus shedding by macaques.
2. Cross reactive immunity stimulated by
Herpes simplex infection or Herpes zoster (chicken
pox).
3. Undetected asymptomatic infection in
man. The frequency of this has not yet been adequately
assessed but antibody titers have been found in some monkey handlers
showing no signs of disease.
In a retrospective study of 95 banked sera from monkey handlers at NIH, 3% were
found to be sero-positive, with no history of a bite. NIH is currently
conducting a prospective study of monkey handlers to determine incidence of
antibody specific for Herpes B.
Diagnosis
Diagnosis is by histology, virus culture, and
serology.
Treatment
Anti viral therapy with Acyclovir
(9-[2-hydroxyethoxymethyl] guanine), both in vivo and in vitro efficacy against
B-virus has been
demonstrated. Hyperimmune human B-virus globulin or vaccine is not
currently available. These are from the guidelines established by the
B-Virus Working Group, June 1987:
1. Macaques should be used for research
only when clearly indicated.
2. B virus - free animals should be used
whenever possible and maintained under
conditions to assure maintenance of this status.
3. Direct handling of macaques should be
minimized and appropriate restraint methods
employed (i.e., squeeze cages, chemical restraint, pole and collar etc.).
4. Protective clothing should be worn when
working with macaques or macaque tissues (long
sleeves, gloves, mask, goggles).
5. Cages and
equipment should be maintained free of sharp edges that could cause injuries.
6. Access to areas where macaques are
housed should be limited.
7. Routine screening of animals for B virus
is NOT recommended.
8. Animals with lesions should be
quarantined until lesions have healed.
9. Education and training of personnel
should be assured.
10. An occupational medical service should be
available
a. Employee
serum samples collected and banked annually).
b. All bite
or scratch wounds should be immediately and thoroughly scrubbed with soap and water ( or Modified Dakin's solution: buffered sodium hypochlorite 0.5%) Refer for medical treatment if necessary.
c. All bite
or scratch wounds should be reported, documented, and followed up for one month.
If you get bitten by an NHP or scratched by an NHP or while working in NHP areas
You need to follow the procedure that CLAC has developed in conjunction with EHS.
|
Web page compiled by: Alison D. Pohl, MS, MT, RLATG
© 2005 UConn Health Center. All rights reserved. |